{"DataElement":{"publicId":"5544750","version":"1","preferredName":"Renal Cell Carcinoma Stratification Factor Clinical T Stage","preferredDefinition":"Selected pre-treatment factors by which patients are segregated before randomization to an intervention arm of a renal cell carcinoma clinical protocol based on their clinical T stage criteria from the TNM staging system.","longName":"5544739v1.0:5544741v1.0","context":"ECOG-ACRIN","contextVersion":"1","DataElementConcept":{"publicId":"5544739","version":"1","preferredName":"Renal Cell Carcinoma Stratification Factors","preferredDefinition":"The most common type of kidney cancer. It begins in the lining of the renal tubules in the kidney. The renal tubules filter the blood and produce urine._Selected pre-treatment factors by which patients are segregated to assure equal balance of these factors before randomization to the intervention arms of a clinical protocol.","longName":"2428360v1.0:5544737v1.0","context":"ECOG-ACRIN","contextVersion":"1","ObjectClass":{"publicId":"2428360","version":"1","preferredName":"Renal Cell Carcinoma","preferredDefinition":"Cancer that develops in the lining of the renal tubules, which filter the blood and produce urine.","longName":"C9385","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Renal Cell Carcinoma","conceptCode":"C9385","definition":"A carcinoma arising from the renal parenchyma.  There is a strong correlation between cigarette smoking and the development of renal cell carcinoma.  The clinical presentation includes : hematuria, flank pain and a palpable lumbar mass.  A high percentage of renal cell carcinomas are diagnosed when an ultrasound is performed for other purposes.  Radical nephrectomy is the standard intervention procedure.  Renal cell carcinoma is generally considered to be resistant to radiation treatment and chemotherapy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"053C2A34-0826-693F-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-11","endDate":null,"createdBy":"ALAIS","dateCreated":"2005-11-11","modifiedBy":"ONEDATA","dateModified":"2005-11-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"5544737","version":"1","preferredName":"Stratification Factors","preferredDefinition":"Selected pre-treatment factors by which patients are segregated to assure equal balance of these factors before randomization to the intervention arms of a clinical protocol.","longName":"C16153","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stratification Factors","conceptCode":"C16153","definition":"Selected pre-treatment factors by which patients are segregated to assure equal balance of these factors before randomization to the intervention arms of a clinical protocol.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"3FD8CA83-7B2E-5DA4-E053-F662850AFE65","latestVersionIndicator":"Yes","beginDate":"2016-10-27","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2016-10-27","modifiedBy":"ONEDATA","dateModified":"2016-10-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"3FD8CA83-7B3F-5DA4-E053-F662850AFE65","latestVersionIndicator":"Yes","beginDate":"2016-10-27","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2016-10-27","modifiedBy":"GARRIDOJ","dateModified":"2017-04-26","changeDescription":"Created for EA8143, JG 10/27/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"5544741","version":"1","preferredName":"Clinical T Stage","preferredDefinition":"The extent of a cancer in the body. Staging is usually based on the size of the tumor, whether lymph nodes contain cancer, and whether the cancer has spread from the original site to other parts of the body.","longName":"5544741v1.0","context":"ECOG-ACRIN","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"15","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":">Clinical T2","valueDescription":"Greater Than Clinical T2 Stage Finding","ValueMeaning":{"publicId":"5544742","version":"1","preferredName":"Greater Than Clinical T2 Stage Finding","longName":"5544742","preferredDefinition":"A statement about the relative size or order of two objects specifying that an object of interest exceeds another object in quantity or measure or value or status.: Relating to the examination and treatment of patients dependent on direct observation.  The term may also refer to the institution (clinic) providing this activity.: A general term that refers to a TNM finding of primary tumor growth beyond the level of in situ cancer, minimal subepithelial invasion, or minimal greatest diameter. The definition of T2 TNM finding depends on the specific type of cancer that it refers to; for example, for breast cancer it refers to primary tumor that is more than 2.0 cm, but not more than 5.0 cm in greatest dimension; for cutaneous melanoma it refers to primary tumor that is 1.01 to 2 mm in thickness, with or without ulceration; for colorectal cancer it refers to primary tumor with invasion into the muscularis propria; and for bladder cancer it refers to primary tumor with invasion into the muscle layer.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Greater Than","conceptCode":"C61584","definition":"A statement about the relative size or order of two objects specifying that an object of interest exceeds another object in quantity or measure or value or status.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Clinical","conceptCode":"C25398","definition":"Relating to the examination and treatment of patients dependent on direct observation.  The term may also refer to the institution (clinic) providing this activity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"T2 TNM Finding","conceptCode":"C48724","definition":"A general term that refers to a TNM finding of primary tumor growth beyond the level of in situ cancer, minimal subepithelial invasion, or minimal greatest diameter. The definition of T2 TNM finding depends on the specific type of cancer that it refers to; for example, for breast cancer it refers to primary tumor that is more than 2.0 cm, but not more than 5.0 cm in greatest dimension; for cutaneous melanoma it refers to primary tumor that is 1.01 to 2 mm in thickness, with or without ulceration; for colorectal cancer it refers to primary tumor with invasion into the muscularis propria; and for bladder cancer it refers to primary tumor with invasion into the muscle layer.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3FD8CA1B-51AC-734E-E053-F662850AB694","latestVersionIndicator":"Yes","beginDate":"2016-10-27","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2016-10-27","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3FD8CA1B-51C5-734E-E053-F662850AB694","beginDate":"2016-10-27","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2016-10-27","modifiedBy":"ONEDATA","dateModified":"2016-10-27","deletedIndicator":"No"},{"value":"Clinical T2","valueDescription":"Clinical T2 Stage Finding","ValueMeaning":{"publicId":"5544743","version":"1","preferredName":"Clinical T2 Stage Finding","longName":"5544743","preferredDefinition":"Relating to the examination and treatment of patients dependent on direct observation.  The term may also refer to the institution (clinic) providing this activity.: A general term that refers to a TNM finding of primary tumor growth beyond the level of in situ cancer, minimal subepithelial invasion, or minimal greatest diameter. The definition of T2 TNM finding depends on the specific type of cancer that it refers to; for example, for breast cancer it refers to primary tumor that is more than 2.0 cm, but not more than 5.0 cm in greatest dimension; for cutaneous melanoma it refers to primary tumor that is 1.01 to 2 mm in thickness, with or without ulceration; for colorectal cancer it refers to primary tumor with invasion into the muscularis propria; and for bladder cancer it refers to primary tumor with invasion into the muscle layer.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clinical","conceptCode":"C25398","definition":"Relating to the examination and treatment of patients dependent on direct observation.  The term may also refer to the institution (clinic) providing this activity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"T2 TNM Finding","conceptCode":"C48724","definition":"A general term that refers to a TNM finding of primary tumor growth beyond the level of in situ cancer, minimal subepithelial invasion, or minimal greatest diameter. The definition of T2 TNM finding depends on the specific type of cancer that it refers to; for example, for breast cancer it refers to primary tumor that is more than 2.0 cm, but not more than 5.0 cm in greatest dimension; for cutaneous melanoma it refers to primary tumor that is 1.01 to 2 mm in thickness, with or without ulceration; for colorectal cancer it refers to primary tumor with invasion into the muscularis propria; and for bladder cancer it refers to primary tumor with invasion into the muscle layer.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3FD8CA1B-51D2-734E-E053-F662850AB694","latestVersionIndicator":"Yes","beginDate":"2016-10-27","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2016-10-27","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3FD8CA1B-51ED-734E-E053-F662850AB694","beginDate":"2016-10-27","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2016-10-27","modifiedBy":"ONEDATA","dateModified":"2016-10-27","deletedIndicator":"No"},{"value":"Clinical T1","valueDescription":"Clinical T1 Stage Finding","ValueMeaning":{"publicId":"5632808","version":"1","preferredName":"Clinical T1 Stage Finding","longName":"5632808","preferredDefinition":"Relating to the examination and treatment of patients dependent on direct observation.  The term may also refer to the institution (clinic) providing this activity.: A clinical and/or pathologic primary tumor TNM finding indicating that the cancer is limited to the site of growth.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clinical","conceptCode":"C25398","definition":"Relating to the examination and treatment of patients dependent on direct observation.  The term may also refer to the institution (clinic) providing this activity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"T1 TNM Finding","conceptCode":"C48720","definition":"A clinical and/or pathologic primary tumor TNM finding indicating that the cancer is limited to the site of growth.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"46D9FDFC-153C-4A2A-E053-F662850A1735","latestVersionIndicator":"Yes","beginDate":"2017-01-24","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-01-24","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"46D9FDFC-1557-4A2A-E053-F662850A1735","beginDate":"2017-01-24","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-01-24","modifiedBy":"ONEDATA","dateModified":"2017-01-24","deletedIndicator":"No"},{"value":"Clinical T1/T2","valueDescription":"Clinical T1 Stage Finding Or T2 Stage Finding","ValueMeaning":{"publicId":"6013472","version":"1","preferredName":"Clinical T1 Stage Finding Or T2 Stage Finding","longName":"6013472","preferredDefinition":"Relating to the examination and treatment of patients dependent on direct observation.  The term may also refer to the institution (clinic) providing this activity.: A clinical and/or pathologic primary tumor TNM finding indicating that the cancer is limited to the site of growth.: An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.: A general term that refers to a TNM finding of primary tumor growth beyond the level of in situ cancer, minimal subepithelial invasion, or minimal greatest diameter. The definition of T2 TNM finding depends on the specific type of cancer that it refers to; for example, for breast cancer it refers to primary tumor that is more than 2.0 cm, but not more than 5.0 cm in greatest dimension; for cutaneous melanoma it refers to primary tumor that is 1.01 to 2 mm in thickness, with or without ulceration; for colorectal cancer it refers to primary tumor with invasion into the muscularis propria; and for bladder cancer it refers to primary tumor with invasion into the muscle layer.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clinical","conceptCode":"C25398","definition":"Relating to the examination and treatment of patients dependent on direct observation.  The term may also refer to the institution (clinic) providing this activity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"T1 TNM Finding","conceptCode":"C48720","definition":"A clinical and/or pathologic primary tumor TNM finding indicating that the cancer is limited to the site of growth.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Or","conceptCode":"C37998","definition":"An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"T2 TNM Finding","conceptCode":"C48724","definition":"A general term that refers to a TNM finding of primary tumor growth beyond the level of in situ cancer, minimal subepithelial invasion, or minimal greatest diameter. The definition of T2 TNM finding depends on the specific type of cancer that it refers to; for example, for breast cancer it refers to primary tumor that is more than 2.0 cm, but not more than 5.0 cm in greatest dimension; for cutaneous melanoma it refers to primary tumor that is 1.01 to 2 mm in thickness, with or without ulceration; for colorectal cancer it refers to primary tumor with invasion into the muscularis propria; and for bladder cancer it refers to primary tumor with invasion into the muscle layer.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5CDB8543-6673-3863-E053-F662850A0553","latestVersionIndicator":"Yes","beginDate":"2017-10-31","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-10-31","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5CDB8543-668E-3863-E053-F662850A0553","beginDate":"2017-10-31","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-10-31","modifiedBy":"ONEDATA","dateModified":"2017-10-31","deletedIndicator":"No"},{"value":"Clinical T3/T4","valueDescription":"Clinical T3 Stage Finding Or T4 Stage Finding","ValueMeaning":{"publicId":"6041931","version":"1","preferredName":"Clinical T3 Stage Finding Or T4 Stage Finding","longName":"6041931","preferredDefinition":"Relating to the examination and treatment of patients dependent on direct observation.  The term may also refer to the institution (clinic) providing this activity.: A clinical and/or pathologic primary tumor TNM finding usually indicating that the cancer is locally invasive, without infiltration of adjacent structures.: An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.: A clinical and/or pathologic primary tumor TNM finding indicating direct invasion of adjacent structures by cancer.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clinical","conceptCode":"C25398","definition":"Relating to the examination and treatment of patients dependent on direct observation.  The term may also refer to the institution (clinic) providing this activity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"T3 TNM Finding","conceptCode":"C48728","definition":"A clinical and/or pathologic primary tumor TNM finding usually indicating that the cancer is locally invasive, without infiltration of adjacent structures.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Or","conceptCode":"C37998","definition":"An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"T4 TNM Finding","conceptCode":"C48732","definition":"A clinical and/or pathologic primary tumor TNM finding indicating direct invasion of adjacent structures by cancer.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6016FEB0-69B5-1E16-E053-F662850A77A7","latestVersionIndicator":"Yes","beginDate":"2017-12-11","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-12-11","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6016FEB0-69D0-1E16-E053-F662850A77A7","beginDate":"2017-12-11","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-12-11","modifiedBy":"ONEDATA","dateModified":"2017-12-11","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2428501","version":"1","preferredName":"Stage","preferredDefinition":"The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"C16899","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"053C2A34-089B-693F-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-11","endDate":null,"createdBy":"ALAIS","dateCreated":"2005-11-11","modifiedBy":"ONEDATA","dateModified":"2005-11-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"3FD8CA1B-5192-734E-E053-F662850AB694","latestVersionIndicator":"Yes","beginDate":"2016-10-27","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2016-10-27","modifiedBy":"GARRIDOJ","dateModified":"2017-12-11","changeDescription":"Created for EA8143, JG 10/27/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"Clinical T Stage","type":"Preferred Question Text","description":"Clinical T Stage","url":null,"context":"ECOG-ACRIN"}],"origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"3FD90CD1-3F94-2345-E053-F662850AC8A4","latestVersionIndicator":"Yes","beginDate":"2016-10-27","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2016-10-27","modifiedBy":"GARRIDOJ","dateModified":"2017-04-26","changeDescription":"Created for EA8143, JG 10/27/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}